Resources

Contact us

BIOVECTRA offers a number of resources to help keep you up to date on industry trends and activities. Meet with us at events, follow us on LinkedIn, and explore the following resources for educational content.

  • Categories

A computer screen displays a presentation titled "Technology Transfer and Scale-Up of a High-Density E. coli Fermentation" with a laboratory background.

Technology Transfer and Scale-Up of a High-Density E. coli Fermentation from a 200 L Stainless Steel to a 1,000 L Single-Use Fermenter

White Paper

While single-use systems are common in mammalian cell culture, their adoption in microbial fermentation has been slower due to the high demands of oxygen transfer and cooling. ABEC’s Custom Single Run (CSR®) technology

Read More

A computer monitor displays "Bioreagents Catalogue February 2024" with a colorful geometric design. Text is bold and vibrant against a blue background.

Bioreagents Catalogue

Catalogue

At BIOVECTRA, we’re committed to advancing your bioprocessing capabilities, and our selection of high-quality bioprocessing reagents is here to make it happen. Whether you’re in the early stages of research…

Download Catalogue

The image shows a computer screen displaying a webinar titled "Unleashing the Potential of ADCs with High-Quality Bioreagents" by Biovectra.

Webinar: Unleashing the Potential of ADCs with High-Quality Bioreagents

On-Demand Webinar

ADCs are an advanced approach in the field of biomedicine that aims to target and treat various diseases in innovative ways, though there are often challenges which require innovative solutions for development […]

View Video

Brian Lowery Interview

Take a sneak peek of our new, cutting-edge biomanufacturing facility coming in late 2023​

Video

Join Bryan Lowery, VP & GM mRNA Vaccine and pDNA Operations, as he unveils our new, cutting-edge biomanufacturing facility, set to open its doors in late 2023. […]

View Video

A computer screen displays a BioPharm International article titled "Optimizing Fermentation Processes for Biologics Manufacturing." It features various related ads and navigation menus.

Optimizing Fermentation Processes for Biologics Manufacturing

Article

The recent resurgence in microbial fermentation for biologics production can be attributed to many factors. Advances in biochemistry and a growing understanding of when glycosylation is not needed […]

Read More

Computer monitor displaying an article titled "Managing Risk in Cutting-Edge mRNA Therapeutics" with images and text related to pharmaceutical topics.

Managing Risk in Cutting-Edge mRNA Therapeutics

Article

Drug development, regardless of the modality, invariably involves some level of risk. As mRNA therapeutics advance, they too will face such risks, including some […]

Read More

A computer screen displays an online article titled "Building on Experience and Investing in an Integrated mRNA Offering" on Pharma's Almanac website.

Building on Experience and Investing in an Integrated mRNA Offering

Article

The outlook for mRNA vaccines and therapeutics continues to be promising, with demand expected to increase as many candidates move into late-stage clinical development and on toward commercialization. With […]

Read More

A person is featured on a computer screen displaying an article about BioVectra. The webpage includes an interview video and descriptive text.

Interview with BIOVECTRA’s Marc Sauer at DCAT

Interview

BIOVECTRA is a global CDMO with a 52 year history – and a one stop shop for our clients. Our growth, in recent years, has been explosive and we’ve made big moves into biologics in recent years. Our new mRNA and Biomanufacturing facility opens […]

View Video

A computer screen displays information about CHEMUK 2023 at the NEC Birmingham, including images of scientific activities, related text, and a chemistry article.

Flow Chemistry for On-Demand Production of Essential Bioreagents

Article

Pharmaceutical supply chains are susceptible to sudden changes in demand or disruptions in what is still largely a centralized manufacturing system. This was highlighted during the COVID-19 pandemic, when access to vaccines, medications and test […]

Read More

A desktop monitor displays a magazine article about BioVectra's biologics expansion, featuring a person. Technical diagrams and text are included.

BIOVECTRA’s Biologics Expansion

Article

BIOVECTRA, a CDMO based in Atlantic Canada has established its presence in the industry – and it is not slowing down any time soon. From its experience providing diagnostic reagents, enzymes and APIs, it has over the past five decades evolved it’s product […]

Read More

A computer monitor displays an article on combating viral threats with vaccine advances, featuring related images and links, on the Pharmaceutical Technology website.

Combatting Future Viral Threats with Vaccine Advances

Interview

Since the beginning of the COVID-19 pandemic, pharmaceutical organizations have experienced major changes, a prime example of which has been the rising requirement for collaborations on multiple different fronts across the industry […]

Read More

A computer screen displays a BioPharm article on microbial fermentation in biologics. The layout includes text, images, and navigation menus.

High-Growth Microbial Fermentation for the Manufacture of Biologics

Article

Biologics have revolutionized drug delivery, offering innovative therapies for a range of diseases, including cancers, autoimmune and other genetic disorders, and infectious diseases. To meet booming demand […]

Read More

SEO plus – Test

  • 20+ years at GSK, leading R&D activities on multiple vaccine programs
  • Recently held positions in industry include: Senior Director (Function Head), Protein Biochemistry; Director, Antigen Design & Prototype Production; and, Associate Director, Antigen Design and Protein Characterization.
  • Key areas of expertise are:
    • Process development of protein Biologics/Recombinant Antigens
    • Recombinant protein expression (mammalian, insect, yeast, bacterial)
    • Production/design of Viral Vectors, mRNA vaccines, Bacterial outer membrane vesicles
    • Protein Engineering and Structural Biology
    • Defining quality attributes, biophysical characterization of proteins, and analytical strategy
  • Post graduate degrees in Functional Genomics (Université Laval) and Bioinformatics (MIT); M. Sc. Microbiology and Immunology (Laval).
  • 25+ Patent & 5 Scientific Publications

Normand Blais – Senior Director Development & Innovation, Biologics

  • 20+ years at GSK, leading R&D activities on multiple vaccine programs
  • Recently held positions in industry include: Senior Director (Function Head), Protein Biochemistry; Director, Antigen Design & Prototype Production; and, Associate Director, Antigen Design and Protein Characterization.
  • Key areas of expertise are:
    • Process development of protein Biologics/Recombinant Antigens
    • Recombinant protein expression (mammalian, insect, yeast, bacterial)
    • Production/design of Viral Vectors, mRNA vaccines, Bacterial outer membrane vesicles
    • Protein Engineering and Structural Biology
    • Defining quality attributes, biophysical characterization of proteins, and analytical strategy
  • Post graduate degrees in Functional Genomics (Université Laval) and Bioinformatics (MIT); M. Sc. Microbiology and Immunology (Laval).
  • 25+ Patent & 5 Scientific Publications

Oliver Technow - Chief Executive Officer

  • Industry Master Degree from Frankfurt Chamber of Commerce, Frankfurt Germany.
  • More than 20 years of global pharmaceutical industry experience.
  • Held numerous leadership positions in commercial development, marketing and brand management, and lifecycle management and has extensive product launch and market access expertise in Europe and North America.
  • In 1997, joined Eisai GmbH in Frankfurt, Germany and in 2002, was appointed Director, CNS Business Unit; in 2006, was appointed Vice President, Head of Global Marketing for Eisai Inc. in Woodcliff Lake, NJ;  in 2011, was appointed Vice President, Established Products Business Unit; in 2013, was appointed President & General Manager for Eisai Limited in Mississauga, ON.
  • Appointed President of BIOVECTRA Inc., December 10, 2015.
  • Board Director for BIOTECanada
  • Member of the Steering Council of Innovative Medicines Canada (IMC)
  • In 2017, appointed to the Government of Canada’s Health/Bio-sciences Strategic Economic Table
  • In November 2019, promoted to Chief Executive Officer at BIOVECTRA
  • In June 2020, named new Chair of PEI BioAlliance Board of Directors